Contineum Therapeutics (CTNM) EPS (Basic) (2023 - 2026)
Contineum Therapeutics' (CTNM) quarterly EPS (Basic) came in at -$1.03 in Q1 2026, down 66.57% year-on-year from -$3.08 in Q1 2025, and down 18.76% quarter-over-quarter from -$0.87 in Q4 2025.
Contineum Therapeutics (CTNM) EPS (Basic) (2023 - 2026) Analysis & Trends
Contineum Therapeutics' EPS (Basic) history runs 4 years deep, the most recent figure standing at -$1.03 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 66.57% year-over-year to -$1.03 in Q1 2026; TTM through Mar 2026 was -$2.44, a 26.93% decrease from a year earlier, with the FY2025 full-year figure at -$4.18, down 91.5% from the prior year.
- EPS (Basic) declined to -$1.03 in Q1 2026 per CTNM's latest filing, from -$0.87 in the prior quarter.
- Across five years, EPS (Basic) topped out at $18.11 in Q2 2023 and bottomed at -$3.55 in Q1 2024.
- The 4-year median for EPS (Basic) is -$0.62 (2025), against an average of $0.29.
- Across the five-year window, EPS (Basic) tumbled 102.13% in 2024 and surged 82.6% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at -$3.17 in 2023, then soared by 76.27% to -$0.75 in 2024, then dropped by 15.19% to -$0.87 in 2025, then slipped by 18.76% to -$1.03 in 2026.
- Per Business Quant, the three latest CTNM EPS (Basic) figures stand at -$1.03 (Q1 2026), -$0.87 (Q4 2025), and -$0.45 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.16 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 0.00 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 0.00 |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 7.59 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -2.29 |
| 10 | Contineum Therapeutics | 536.56 Mn | 536.56 Mn | - | -1.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.03 |
| Dec 31, 2025 | -0.87 |
| Sep 30, 2025 | -0.45 |
| Jun 30, 2025 | -0.62 |
| Mar 31, 2025 | -0.62 |
| Dec 31, 2024 | -0.75 |
| Sep 30, 2024 | -0.40 |
| Jun 30, 2024 | -0.39 |
| Mar 31, 2024 | -3.55 |
| Dec 31, 2023 | -3.17 |
| Sep 30, 2023 | -0.35 |
| Jun 30, 2023 | 18.11 |
| Mar 31, 2023 | -2.12 |